Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.63 Insider Own3.31% Shs Outstand54.16M Perf Week-3.15%
Market Cap66.62M Forward P/E- EPS next Y- Insider Trans3.34% Shs Float52.37M Perf Month-15.17%
Income-29.95M PEG- EPS next Q- Inst Own14.02% Short Float14.54% Perf Quarter-39.11%
Sales0.00M P/S- EPS this Y- Inst Trans-13.78% Short Ratio22.09 Perf Half Y-47.66%
Book/sh0.26 P/B4.65 EPS next Y- ROA-87.78% Short Interest7.61M Perf Year-48.75%
Cash/sh0.10 P/C12.55 EPS next 5Y- ROE-173.88% 52W Range1.04 - 3.23 Perf YTD-54.78%
Dividend Est.- P/FCF- EPS past 5Y17.22% ROI-120.60% 52W High-61.92% Beta1.05
Dividend TTM- Quick Ratio1.18 Sales past 5Y-16.43% Gross Margin- 52W Low18.27% ATR (14)0.14
Dividend Ex-DateAug 28, 1996 Current Ratio1.67 EPS Y/Y TTM22.84% Oper. Margin0.00% RSI (14)35.07 Volatility8.20% 11.83%
Employees- Debt/Eq0.88 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price8.40
Option/ShortYes / No LT Debt/Eq0.74 EPS Q/Q27.22% Payout- Rel Volume0.89 Prev Close1.27
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsMay 16 BMO Avg Volume344.75K Price1.23
SMA20-14.02% SMA50-23.90% SMA200-35.63% Trades Volume306,175 Change-3.15%
Date Action Analyst Rating Change Price Target Change
Jan-13-20Initiated H.C. Wainwright Buy $18
Mar-02-15Initiated Dawson James Buy $3
May-16-24 09:08AM
May-08-24 04:02PM
Apr-23-24 09:00AM
09:00AM Loading…
Mar-19-24 09:00AM
Mar-06-24 08:45AM
Feb-15-24 08:00AM
Feb-14-24 05:11PM
Feb-13-24 12:00PM
Feb-09-24 08:30AM
Feb-06-24 09:00AM
Jan-31-24 09:00AM
Dec-22-23 08:00AM
Dec-04-23 08:30AM
04:15PM Loading…
Nov-20-23 04:15PM
Nov-16-23 08:30AM
Nov-09-23 08:52AM
Oct-30-23 09:20AM
Oct-24-23 08:00AM
Oct-23-23 09:15AM
Oct-19-23 08:00AM
Oct-09-23 07:50AM
Oct-05-23 08:45AM
Sep-26-23 09:00AM
Aug-11-23 08:07AM
Jul-31-23 05:49AM
Jul-20-23 11:36AM
Jul-17-23 09:23PM
04:05PM Loading…
Jul-14-23 09:15AM
Jul-11-23 08:45AM
Jun-22-23 10:19AM
May-16-23 09:17AM
May-15-23 02:18PM
May-12-23 04:35PM
Apr-27-23 09:12PM
Apr-19-23 09:00AM
Mar-08-23 09:00AM
Mar-03-23 09:00AM
Feb-27-23 05:26AM
Feb-15-23 09:00AM
Jan-03-23 11:57AM
Dec-28-22 09:00AM
Nov-22-22 12:21PM
Oct-17-22 08:50AM
Sep-12-22 09:00AM
Sep-07-22 08:45AM
Aug-24-22 05:45AM
Aug-19-22 08:45AM
Aug-15-22 09:00AM
Aug-08-22 08:45AM
Jul-14-22 10:00AM
Jun-08-22 09:00AM
Jun-07-22 07:30AM
May-27-22 09:00AM
May-19-22 05:10AM
May-16-22 08:50AM
Apr-22-22 09:21AM
Feb-16-22 04:30AM
Feb-14-22 09:00AM
Jan-24-22 02:48PM
Jan-11-22 04:44AM
Dec-22-21 09:00AM
Oct-22-21 08:00AM
Aug-25-21 04:00AM
Aug-16-21 09:00AM
Jul-08-21 12:16PM
Jul-07-21 08:21PM
Jul-06-21 11:16AM
Jul-05-21 10:06PM
Jul-03-21 10:00PM
Jul-02-21 11:20AM
Jun-30-21 09:00AM
Jun-29-21 11:15PM
Jun-28-21 10:34AM
Jun-25-21 08:30AM
Jun-22-21 10:25PM
Jun-17-21 01:09PM
Jun-11-21 11:49AM
Jun-09-21 06:30AM
Jun-08-21 09:03PM
Jun-05-21 06:15AM
May-27-21 02:33PM
May-18-21 09:00AM
Apr-28-21 03:26PM
Apr-15-21 03:41PM
Apr-07-21 03:15AM
CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KERSTEN GEERT RChief Executive OfficerMay 08 '24Buy1.3930,00041,7001,195,309May 09 09:19 AM
Watson Robert EugeneDirectorMay 08 '24Buy1.3920,00027,80024,431May 10 09:04 AM
PRICHEP PATRICIA BSenior Vice PresidentMay 08 '24Buy1.398,00011,120232,326May 09 01:07 PM